About: Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation
Creator	Cheng, Gregory Wang, Jianli He, · Wang, Yudong Lau, · Zhu, Zhijun Liu, Hongling Li, Guangming Liu, Zhenwen Sun, Libo Zhang, Dali Zhou, Shuangnan Zhu, Jiye Qiang He, ·
source	Medline; PMC
abstract	Annually, around 850 liver transplantation is performed in Beijing, China. Recently, the new coronavirus pneumonia (COVID-19) caused by 2019 novel coronavirus (2019-nCoV) has affected nearly 200 countries worldwide. 2019-nCov can cause severe lung disease, multiple-organ damage, and significant mortalities. Liver transplant recipients, because of long-term oral immunosuppressant effects, may be more susceptible to 2019-nCoV infection and have a worse prognosis than the general population. It is urgent to set up guidelines for the prevention, diagnosis, and treatment of COVID-19 in liver transplant recipients. In this article, we reviewed the clinical aspects of 2019-nCoV infection, characteristics of liver transplant recipients, immunosuppressant usage, and potential drug interactions to provide recommendations to clinical staff managing liver transplant recipients during the COVID-19 epidemic.
has issue date	2020-04-10(xsd:dateTime)
bibo:doi	10.1007/s12072-020-10043-z
bibo:pmid	32277387
has license	no-cc
sha1sum (hex)	7f86d944e9617ff928c38fcc8107bc45ff9e3901
schema:url	https://doi.org/10.1007/s12072-020-10043-z
resource representing a document's title	Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation
has PubMed Central identifier	PMC7146012
has PubMed identifier	32277387
schema:publication	Hepatol Int
resource representing a document's body	covid:7f86d944e9617ff928c38fcc8107bc45ff9e3901#body_text
is schema:about of	named entity 'pneumonia' named entity 'infection' named entity 'TRANSPLANT RECIPIENTS' named entity 'SEVERE' named entity 'CHINA' named entity 'POTENTIAL' named entity 'LUNG DISEASE' named entity 'EFFECTS' named entity 'ARTICLE' named entity 'URGENT' named entity 'TO PROVIDE' named entity 'ORAL' named entity 'IMMUNOSUPPRESSANT' named entity 'USAGE' named entity 'MANAGING' named entity 'CLINICAL ASPECTS' named entity 'COUNTRIES' named entity 'REVIEWED' named entity 'liver transplant' named entity '2019' named entity 'Liver transplant' named entity 'effects' named entity 'COVID-19' named entity 'COVID' named entity 'long-term' named entity 'liver transplantation' named entity 'general population' named entity 'Liver transplant' named entity 'epidemic' named entity 'immunosuppressant' named entity 'working party' named entity 'liver transplantation' named entity 'liver transplantation' named entity 'severe pneumonia' named entity 'pathogens' named entity '2019-nCoV' named entity 'COVID-19' named entity 'ACE2 receptor' named entity '2019-nCoV' named entity 'chronic hepatitis' named entity 'respiratory symptoms' named entity '2019-nCoV' named entity '2019-nCoV' named entity 'infection' named entity 'COVID' named entity 'lymphopenia' named entity '2019-nCoV' named entity 'liver transplant' named entity 'glass shadows' named entity 'lopinavir/ritonavir' named entity 'Organ transplant' named entity 'Fever' named entity 'WHO' named entity 'prevention and control' named entity 'higher risk' named entity 'calcineurin inhibitor' named entity 'nucleic acid sequences' named entity 'ARDS' named entity 'nucleic acid detection' named entity 'liver transplant' named entity '2019-nCoV' named entity 'infection' named entity 'metabolic' named entity 'envelope protein' named entity 'tested positive' named entity 'RNA' named entity 'Mycoplasma pneumoniae' named entity 'COVID-19'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software